Osteoarthritis is a chronic condition that affects our joints, mainly the knees, hips, lower back and neck. It affects over 30 million Americans. Overuse of joints cause the cartilage to wear down over time, eventually resulting in bone on bone articulation in our joints. Unfortunately there is no cure and ultimately the result is a joint replacement. Recently, Cannabidiol has been used by chronic pain sufferers to reduce pain, inflammation and swelling.
How exactly does CBD work in the body? Studies suggest that CBD reduces inflammation by inhibiting cell proliferation, inducing apoptosis, suppressing cytokine production, and inducing T-regulatory cells (Nagarkatti, 2009). In other words, CBD quiets the inflammatory response, thus breaking the cycle of chronic pain. In Osteoarthritis, there is a constant inflammatory stimulus within the joint. After years and years of chronic inflammation, fibrosis and scar tissue build up in the joint. Not only does CBD quiet this stimulus, but it gives the body a chance to reabsorb the damaged tissue and heal.
Diagnosis of OA in the athlete is often delayed and difficult, because of high tolerance to pain, as well as the athlete’s preference for expedited return to play. (Amoako, 2014). Current therapies, including pain management, improved nutrition and regular programs for exercise do not lead to the resolution of osteoarthritis (Maiese, 2016). This makes NSAIDS such as ibuprofen and naproxen one of the most widely used medications for people with OA. Recently, many people are turning to CBD oil to avoid the potential harmful side effects of NSAIDS and opioids.
When starting CBD, proper dosage and route of administration can be confusing for consumers. Most people opt for sublingual drops. Not sure where to start? Stop in at Two Moons CBD for a free consultation with me. We can start you on a regimen that fit your needs. As always, never use CBD in lieu of consulting with your healthcare provider. Email me today and let me guide you on your path to wellness. TwoMoonsCBDnurse@gmail.com
1. Nagarkatti, Prakash, et al. “Cannabinoids as novel anti-inflammatory drugs” Future Med Chem. 2009. 1(7): 1333-1349.
2. Amoako AO and Pujalte GGA. Osteoarthritis in Young, Active, and Athletic Individuals. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders. 2014:7; 27–32.
3. Maiese K. Picking a Bone With WISP1 (CCCN4): New Strategies Against Degenerative Joint Disease. J Transl Sci. 2016.
FDA DisclaimerThe statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from healthcare practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product.